Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
Alejandra Mijangos-Trejo, Natalia Nuño‐Lámbarri, Varenka J. Barbero-Becerra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14918-14918
Open Access | Times Cited: 17

Showing 17 citing articles:

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 18
Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)—A Randomized Pilot Trial
Naama Reshef, Uri Gophna, Leah Reshef, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1571-1571
Open Access | Times Cited: 6
Relevant Aspects of Combined Protocols for Prevention of N(M)AFLD and Other Non‐Communicable Diseases
Luis A. Videla, Rodrigo Valenzuela, Jessica Zúñiga‐Hernández, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 7
Closed Access | Times Cited: 5
Probiotics for the treatment of hyperlipidemia: Focus on gut-liver axis and lipid metabolism
Min You, Liping Zhou, Fan Wu, et al.
Pharmacological Research (2025) Vol. 214, pp. 107694-107694
Open Access
Assessing the impact of concurrent high-fructose and high-saturated fat diets on pediatric metabolic syndrome: A review
Manuel Alejandro Vargas-Vargas, Marcela González-Montoya, Olin Torres‐Isidro, et al.
World Journal of Clinical Pediatrics (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 3
A mini-review on prebiotic inulin to prevent and treat non-alcoholic fatty liver disease
Nelson Kei, Susana Lauw, Vincent Wai‐Sun Wong, et al.
Food Bioscience (2024) Vol. 61, pp. 104679-104679
Closed Access | Times Cited: 3
Vinpocetine and Lactobacillus improve fatty liver in rats: role of adiponectin and gut microbiome
Ahmed M. El-Baz, Ahmed Shata, Nehal A. Nouh, et al.
AMB Express (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
The effect of ertugliflozin in patients with nonalcoholic fatty liver disease associated with type 2 diabetes mellitus: A randomized controlled trial
Adil Khaliq, Haroon Badshah, Yasar Shah, et al.
Medicine (2024) Vol. 103, Iss. 45, pp. e40356-e40356
Open Access | Times Cited: 2
Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice
Kaikai Lu, Yimeng Zhou, Lei He, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 6
Closed Access | Times Cited: 1
Probiotics—role in alleviating the impact of alcohol liver disease and alcohol deaddiction: a systematic review
Grisilda Vidya Bernhardt, Pooja Shivappa, Janita R. T. Pinto, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Administration of Alistipes indistinctus prevented the progression from nonalcoholic fatty liver disease to nonalcoholic steatohepatitis by enhancing the gut barrier and increasing Lactobacillus spp.
Xiaoxue Xu, Yanrong Wang, Xiaofei Wu, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 741, pp. 151033-151033
Closed Access
Lactobacillus sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice
Titilayo Olotu, Jessica M. Ferrell
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2488-2488
Open Access
Prebiotics and Probiotics: Healthy Biotools for Molecular Integrative and Modulation Approaches 2.0
Jaime Aguilera, Abdelali Daddaoua
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4872-4872
Open Access
Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease
Samradhi Singh, Mona Kriti, Roberto Catanzaro, et al.
Livers (2024) Vol. 4, Iss. 3, pp. 435-454
Open Access
The probiotic Lacticaseibacillus rhamnosus SD11 alleviates the progression of liver and colon damage through modulation of inflammation and tight junction proteins in streptozotocin-induced diabetic mice
Waraporn Ruathong, Pissared Khuituan, Saranya Peerakietkhajorn, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0313395-e0313395
Open Access
Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A General Overview and Approach in Clinical Practice
Nwe Ni Than
Medical Research Archives (2023) Vol. 11, Iss. 11
Open Access
Functional properties of chia (Salvia hispanica L.) flour, its hydrolyzed protein and phenolic extract on microbiota and gut health in vivo
Marcella Duarte Villas Mishima
(2023)
Open Access
Page 1

Scroll to top